PBL attending Bioprocessing Summit Europe

We are pleased to announce that we will be attending Bioprocessing Summit Europe from 20-22 March in Lisbon.  Do come and visit us at Stand No 14 and also see our poster on  “A QbD approach to Developing Protein Therapeutics”.  We are also able to offer a discount code of up to $200 for our contacts who wish to register and attend the event.

read more

PBL Spporting Royal Society of Biology

Porton Biopharma is pleased to be the official sponsor at the Royal Society of Biology’s President’s Dinner. Following the Society’s Annual General Meeting on 2 May in London, the dinner celebrates Professor Dame Julia Goodfellow DBE CBE CBiol FRSB succeeding Professor Dame Jean Thomas FRS FMedSci Hon FRSB.

read more

PBL opens new pharmaceutical development labs

Porton Biopharma Limited (PBL) has officially opened and named their new multi-million pound pharmaceutical laboratories with a ribbon cutting ceremony lead by Baroness Jane Scott of Bybrook OBE, Leader of Wiltshire Council.  The facility has been named the Atkinson Development Centre (or ADC) in tribute to Professor Tony Atkinson

read more

PBL gains approval to advance next generation anthrax vaccine

Porton Biopharma Ltd (PBL) has today announced that it has signed a modification to its contract with the US National Institute of Health’s National Institute of Allergy and Infectious Diseases (NIAID) to advance a next generation intra-nasal anthrax vaccine. The contract modification is worth US$5.6 million.

read more

PBL Opens Quality Accommodation

quality office accomodation

We have opened a brand new suite of office accommodation that will bring together members of Quality Assurance (QA) and other departments into one integrated set of buildings, which will both improve efficiency and also demonstrates the investment that we are making in the company.

read more